Found: 15
Select item for more details and to access through your institution.
Bimekizumab: Short-Term Effectiveness and Safety in Real Clinical Practice in Andalucia, Spain.
- Published in:
- Life (2075-1729), 2024, v. 14, n. 3, p. 281, doi. 10.3390/life14030281
- By:
- Publication type:
- Article
Treatment of severe atopic dermatitis with tralokinumab in clinical practice: short-term effectiveness and safety results.
- Published in:
- Clinical & Experimental Dermatology, 2023, v. 48, n. 9, p. 991, doi. 10.1093/ced/llad153
- By:
- Publication type:
- Article
Multicenter Retrospective Andalusian Study of the Use of Sonidegib for the Treatment of Local Advanced Basal Cell Carcinoma in Real Clinical Practice.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 17, p. 5631, doi. 10.3390/jcm12175631
- By:
- Publication type:
- Article
Guselkumab dosing interval optimization in adult patients with moderate‐to‐severe psoriasis switching from ustekinumab.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 11, p. 1, doi. 10.1111/dth.15835
- By:
- Publication type:
- Article
Guselkumab as a switching strategy after anti‐TNFα, anti‐IL17, or anti‐IL12/23 therapies in moderate‐to‐severe psoriasis.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15760
- By:
- Publication type:
- Article
Validation of a Questionnaire to Assess the Perception of Women with Atopic Dermatitis in Family Planning.
- Published in:
- International Journal of Environmental Research & Public Health, 2022, v. 19, n. 17, p. 10753, doi. 10.3390/ijerph191710753
- By:
- Publication type:
- Article
Super-Responders in Moderate–Severe Psoriasis under Guselkumab Treatment: Myths, Realities and Future Perspectives.
- Published in:
- Life (2075-1729), 2022, v. 12, n. 9, p. 1412, doi. 10.3390/life12091412
- By:
- Publication type:
- Article
Super responders to guselkumab treatment in moderate‐to‐severe psoriasis: a real clinical practice pilot series.
- Published in:
- International Journal of Dermatology, 2022, v. 61, n. 8, p. 1029, doi. 10.1111/ijd.15784
- By:
- Publication type:
- Article
Long-Term Effectiveness and Safety of Biologic and Small Molecule Drugs for Moderate to Severe Atopic Dermatitis: A Systematic Review.
- Published in:
- Life (2075-1729), 2022, v. 12, n. 8, p. 1159, doi. 10.3390/life12081159
- By:
- Publication type:
- Article
Atopic Dermatitis: Background, Objectives and Future Perspectives (Superresponders).
- Published in:
- Life (2075-1729), 2022, v. 12, n. 8, p. 1192, doi. 10.3390/life12081192
- By:
- Publication type:
- Article
Short-Term Effectiveness and Safety of Biologics and Small Molecule Drugs for Moderate to Severe Atopic Dermatitis: A Systematic Review and Network Meta-Analysis.
- Published in:
- Life (2075-1729), 2021, v. 11, n. 9, p. 927, doi. 10.3390/life11090927
- By:
- Publication type:
- Article
Successful response of vulvar lichen sclerosus with NB‐UVB.
- Published in:
- Dermatologic Therapy, 2021, v. 34, n. 2, p. 1, doi. 10.1111/dth.14801
- By:
- Publication type:
- Article
Guselkumab: Mid‐term effectiveness, drug survival, and safety in real clinical practice.
- Published in:
- Dermatologic Therapy, 2021, v. 34, n. 2, p. 1, doi. 10.1111/dth.14798
- By:
- Publication type:
- Article
Prevalence of chronic urticaria refractory to antihistamines in Andalucia, Spain.
- Published in:
- Dermatologic Therapy, 2020, v. 33, n. 6, p. 1, doi. 10.1111/dth.13866
- By:
- Publication type:
- Article
Zosteriform morphea: Wolf's isotopic response in an immunocompetent patient.
- Published in:
- 2011
- By:
- Publication type:
- Case Study